[adoption shares: subsidiary stylus products pass US FDA Review] FAP, adopting the joint-stock announcement, the company's wholly-owned subsidiary recently received a notice from the US Food and Drug Administration (referred to as "US FDA") to adopt medical stylus products to pass the US FDA examination and formally obtain the US market access permit.